The prognostic relationship between donor age and infectious risk in liver transplant patients with nonalcoholic steatohepatitis: Analysis of UNOS database

Dig Liver Dis. 2023 Jun;55(6):751-762. doi: 10.1016/j.dld.2023.01.160. Epub 2023 Feb 15.

Abstract

Background & aims: We investigate the effects of advancing donor age on the prognostic outcomes of patients with NASH who undergo liver transplant (LT), with a specialized attention toward infectious outcomes post-LT.

Methods: The UNOS-STAR registry was used to select 2005 to 2019 LT recipients with NASH, who were stratified by donor age into the following categories: recipients with younger donors (less than 50 years of age-reference), quinquagenarian donors, sexagenarian donors, septuagenarian donors, and octogenarian donors. Cox regression analyses were conducted for all-cause mortality, graft failure, infectious causes of death.

Results: From a total of 8888 recipients, the quinquagenarian, septuagenarian, and octogenarian donor cohorts showed greater risk of all-cause mortality (quinquagenarian: aHR 1.16 95%CI 1.03-1.30; septuagenarian: aHR 1.20 95%CI 1.00-1.44; octogenarian: aHR 2.01 95%CI 1.40-2.88). With advancing donor age, there was an increased risk of death from sepsis (quinquagenarian: aHR 1.71 95% CI 1.24-2.36; sexagenarian: aHR 1.73 95% CI 1.21-2.48; septuagenarian: aHR 1.76 95% CI 1.07-2.90; octogenarian: aHR 3.58 95% CI 1.42-9.06) and infectious causes (quinquagenarian: aHR 1.46 95% CI 1.12-1.90; sexagenarian: aHR 1.58 95% CI 1.18-2.11; septuagenarian: aHR 1.73 95% CI 1.15-2.61; octogenarian: aHR 3.70 95% CI 1.78-7.69).

Conclusion: NASH patients who receive grafts from elderly donors exhibit higher risk of post-LT mortality, especially due to infection.

Keywords: Advancing donor age; Aging and frailty; Liver-transplants; NASH; Post-transplant prognosis.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Graft Survival
  • Humans
  • Liver Transplantation* / adverse effects
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease* / etiology
  • Prognosis
  • Tissue Donors